Investigating the anticancer effects of chitosan-NLC-folate nanohybrid loaded with auraptene on A2780 ovarian cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00210-024-03325-y.pdf
Reference35 articles.
1. Akasaka Y, Hasei S, Ohata Y, Kanna M, Nakatsu Y, Sakoda H et al (2023) Auraptene enhances AMP-activated protein kinase phosphorylation and thereby inhibits the proliferation, migration and expression of androgen receptors and prostate-specific antigens in prostate cancer cells. Int J Mol Sci 24(21):16011
2. Akbari S, Assaran Darban R, Javid H, Esparham A, Hashemy SI (2023) The anti-tumoral role of hesperidin and aprepitant on prostate cancer cells through redox modifications. Naunyn Schmiedebergs Arch Pharmacol 396(12):3559–3567
3. Alharbi HM, Alqahtani T, Alamri AH, Kumarasamy V, Subramaniyan V, Babu KS (2023) Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics. Front Pharmacol 14:1276209
4. Ali A, Ahmed S (2018) A review on chitosan and its nanocomposites in drug delivery. Int J Biol Macromol 109:273–286
5. Alibolandi M, Amel Farzad S, Mohammadi M, Abnous K, Taghdisi SM, Kalalinia F et al (2018) Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38. Artif Cells Nanomed Biotechnol 46(sup2):1003–1014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3